These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 11365434)

  • 1. Indinavir, nelfinavir -- twice a day?
    TreatmentUpdate; 1998 Apr; 10(2):3-4. PubMed ID: 11365434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simplifying drug regimens.
    HIV Hotline; 1998 Mar; 8(1):11. PubMed ID: 11365353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of indinavir/ritonavir 400/100 mg twice daily plus two nucleoside analogues in treatment-naive HIV-1-infected patients with CD4+ T-cell counts <200 cells/mm3: 96-week outcomes.
    Mootsikapun P; Chetchotisakd P; Anunnatsiri S; Boonyaprawit P
    Antivir Ther; 2005; 10(8):911-6. PubMed ID: 16430196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health-related quality of life in HIV patients switching to twice-daily indinavir/ritonavir regimen or continuing with three-times-daily indinavir-based therapy.
    Badía X; Podzamczer D; Moral I; Roset M; Arnaiz JA; Loncà M; Casiró A; Rosón B; Gatell JM;
    Antivir Ther; 2004 Dec; 9(6):979-85. PubMed ID: 15651756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of antiretroviral triple combinations including the protease inhibitor nelfinavir in heavily pretreated children with HIV-1 infection.
    Hoffmann F; Funk M; Linde R; Notheis G; Petropoulou T; Eberle J; Gürtler L; Belohradsky BH; Wintergerst U
    Eur J Med Res; 2002 Jul; 7(7):330-4. PubMed ID: 12176683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update from the 5th Conference on Retroviruses and Opportunistic Infections.
    Vazquez E
    Posit Aware; 1998; 9(3):21-3. PubMed ID: 11365483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salvage with Nelfinavir doesn't always work.
    TreatmentUpdate; 1998 Aug; 10(6):2-3. PubMed ID: 11365702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term efficacy and safety of twice-daily saquinavir soft gelatin capsules (SGC), with or without nelfinavir, and three times daily saquinavir-SGC, in triple combination therapy for HIV infection: 100-week follow-up.
    Greenberg RN; Feinberg J; Goodrich J; Pilson RS; Siemon-Hryczyk P
    Antivir Ther; 2003 Feb; 8(1):37-42. PubMed ID: 12713062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using ritonavir with indinavir in cases of virologic failure.
    TreatmentUpdate; 2001; 12(12):7. PubMed ID: 11570095
    [No Abstract]   [Full Text] [Related]  

  • 10. Data on nevirapine combinations released.
    AIDS Patient Care STDS; 1998 Apr; 12(4):316-7. PubMed ID: 11361960
    [No Abstract]   [Full Text] [Related]  

  • 11. Nelfinavir is number 4 -- but should it bat cleanup, or lead off?
    Mascolini M
    J Int Assoc Physicians AIDS Care; 1997 Jun; 3(6):17-21. PubMed ID: 11364427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lamivudine and indinavir/ritonavir maintenance therapy in highly pretreated HIV-infected patients (Vista ANRS 109).
    Launay O; Duval X; Dalban C; Descamps D; Peytavin G; Certain A; Mouajjah S; Ralaimazava P; Verdon R; Costagliola D; Clavel F;
    Antivir Ther; 2006; 11(7):889-99. PubMed ID: 17302251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combinations of protease inhibitors.
    TreatmentUpdate; 1998 Apr; 10(2):1-3. PubMed ID: 11365433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Merck pushes the envelope with once-daily indinavir.
    TreatmentUpdate; 2001; 12(12):8. PubMed ID: 11570096
    [No Abstract]   [Full Text] [Related]  

  • 15. Crixivan warning: keep to three times a day.
    Gilden D
    GMHC Treat Issues; 1998 Sep; 12(9):2. PubMed ID: 11365805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiretroviral rounds. When success is a pain.
    Bartlett JG; del Rio C
    AIDS Clin Care; 2001 Aug; 13(8):74-5. PubMed ID: 11547461
    [No Abstract]   [Full Text] [Related]  

  • 17. Update on antivirals.
    Proj Inf Perspect; 1997 Nov; (23):8-11. PubMed ID: 11365381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Twice-a-day Crixivan study discontinued.
    Newsline People AIDS Coalit N Y; 1998; ():31. PubMed ID: 11367502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Virologic failure and salvage therapy.
    HIV Hotline; 1998 Mar; 8(1):2-3. PubMed ID: 11365357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic drug monitoring of indinavir and nelfinavir to assess adherence to therapy in human immunodeficiency virus-infected children.
    van Rossum AM; Bergshoeff AS; Fraaij PL; Hugen PW; Hartwig NG; Geelen SP; Wolfs TF; Weemaes CM; De Groot R; Burger DM
    Pediatr Infect Dis J; 2002 Aug; 21(8):743-7. PubMed ID: 12192162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.